InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Selecky Christobel, Director. Officer active across 1 company, notably ImmunityBio, Inc.. In total, 5 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €1.3m. Activity tracked since 16 January 2026. The latest transaction was filed on 1 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Selecky Christobel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
35,064 股@ US$2.980.0011% mcap4.4% 占其流量Common StockSEC:0001849739-26-000014:0
124,414 股@ US$2.990.0038% mcap15.8% 占其流量Common StockSEC:0001849739-26-000014:1
159,478 股@ US$9.02360.015% mcap61.2% 占其流量Common StockSEC:0001849739-26-000014:2
25,000 股@ US$2.980.0008% mcap16.5% 占其流量Common StockSEC:0001849739-26-000004:0
50,000 股@ US$2.980.0015% mcap33.5% 占其流量Common StockSEC:0001849739-26-000002:0
5 条申报中的 5 条
About Selecky Christobel
Christobel Selecky serves as a Director at ImmunityBio, Inc. She contributes to strategic decision-making and oversight of the company's activities. Christobel brings valuable expertise in biotechnology and product development, contributing to the company's leadership. Her commitment to innovation is an asset to ImmunityBio.
